🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

NZ's Fisher & Paykel and ResMed settle global patent disputes

Published 21/02/2019, 07:09 am
NZ's Fisher & Paykel and ResMed settle global patent disputes
FPH
-

Feb 21 (Reuters) - Medical device maker Fisher & Paykel Healthcare FPH.NZ and U.S.-based ResMed RMD.N on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe.

The two companies had been at loggerheads in several countries, ranging from the United Kingdom to Australia and the United States, with each alleging that the other infringed its patents.

In a joint statement, both medical device makers agreed to end all ongoing infringement cases, and said that under the deal neither company will admit any liability or make any payment.

Fisher & Paykel, in a separate release, said the settlement will not impact its net profit guidance for the 2019 financial year.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

USITC to investigate Resmed for alleged patent infringement

NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.